Shift Biosciences, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the appointments of Jill Reckless, Ph.D, as Translation Advisor and Laurence Reid, ...

and Warp Drive Bio (merged with Revolution Medicines), as well as senior executive and business development roles at Alnylam Pharmaceuticals and Millennium Pharmaceuticals. Now focusing his ...

Shift Bioscience has appointed Jill Reckless, Ph.D, as Translation Advisor and Laurence Reid, Ph.D., as Non-Executive ...

ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research ...

Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at ...

Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium Pharmaceuticals ...

Fintel reports that on March 14, 2025, Jefferies initiated coverage of ANI Pharmaceuticals (NasdaqGM:ANIP) with a Buy ...

Fintel reports that on March 12, 2025, JP Morgan initiated coverage of ANI Pharmaceuticals (NasdaqGM:ANIP) with a Overweight ...

Millennium Management holds 1,003K ... its portfolio allocation in ANIP by 20.47% over the last quarter. ANI Pharmaceuticals Background Information (This description is provided by the company.) ...